SafeTide
PrivateLast Round
Accelerator
Aug 20, 2025
Company Overview
SafeTide is a biotechnology company developing low-cost stabilisation technology to keep delicate medicines like insulin stable at room temperature.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
medicinal stabilizationcold-chain logisticsbiotechpharmaceutical supply chainsupramolecular chemistrycold-chain alternativesdrug stabilityroom-temperature storagebiologicspharma R&Dmedical waste reductiondeep tech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SafeTide Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
SafeTide Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 20, 2025 |
SafeTide Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Founders at the University of Cambridge | Accelerator |
SafeTide Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SafeTide's valuation, stock price, and market status.